Phase II study of flavopiridol in patients with advanced colorectal cancer. [electronic resource]
Producer: 20031017Description: 1270-3 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Flavonoids -- administration & dosage
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Magnetic Resonance Imaging
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Piperidines -- administration & dosage
- Probability
- Survival Analysis
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.